Repeated general anesthesia in a patient with Noonan Syndrome
Y Asahi, R Fujii, N Usui, H Kagamiuchi… - Anesthesia …, 2015 - meridian.allenpress.com
Noonan syndrome (NS) is an autosomal dominant disorder characterized by facial
anomalies, short stature, chest deformity, congenital heart diseases, and other …
anomalies, short stature, chest deformity, congenital heart diseases, and other …
Anesthetic management by laryngeal mask airway in a patient with a history of difficult intubation resulting in dental injuries
Y Asahi, R Fujii, N Usui, H Kagamiuchi… - Anesthesia …, 2015 - meridian.allenpress.com
Disabled patients may face respiratory problems during general anesthesia because of
head and neck anomalies. We describe a case of dental treatment under general …
head and neck anomalies. We describe a case of dental treatment under general …
Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash
N Usui, Y Kondo, N Ryota, H Suzuki… - European Journal of …, 2017 - ejhp.bmj.com
Objective The present study aimed to retrospectively examine the effectiveness of
mandatory dexamethasone (m-DEX) strictly monitored by pharmacists collaborating with …
mandatory dexamethasone (m-DEX) strictly monitored by pharmacists collaborating with …
[HTML][HTML] Evaluation of the Preventive Effect of Dexamethasone for Rash in Patients Treated with Pemetrexed
N Usui, Y Kondo, N Okamoto, H Suzuki, M Sando… - Annals of …, 2014 - Elsevier
Purpose: Pemetrexed (PEM) is frequently used in the treatment of non-small cell lung cancer
and malignant pleural mesothelioma. The rash, which is the characteristic side effect of …
and malignant pleural mesothelioma. The rash, which is the characteristic side effect of …
Evaluation of the Safety of a Generic Formulation of Cisplatin in Patients with Thoracic Malignancies
Y Ueda, Y Kondo, H Suzuki, N Okamoto… - Gan to Kagaku ryoho …, 2015 - europepmc.org
Cisplatin (CDDP) is a key drug in the systemic treatment of various solid tumors. Brand-
name CDDP may differ across generic formulations considering various clinical parameters …
name CDDP may differ across generic formulations considering various clinical parameters …
Retrospective Evaluation of the Effect of Aprepitant for Nausea and Vomiting Induced by Cisplatin Chemotherapy
Y Kondo, T Hirashima, M Sakon… - Gan to kagaku …, 2011 - pubmed.ncbi.nlm.nih.gov
[CITATION][C] CLINICAL ANALYSIS OF AFATINIB IN EGFR-TYROSINE KINASE INHIBITOR NAIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER HABORING …
S Nasu, S Takata, K Masuhiro… - …, 2017 - … ST, HOBOKEN 07030-5774, NJ USA